FRIDAY, Oct. 14, 2022 (HealthDay News) — A proposed ban on menthol cigarettes could have a significant impact on smoking rates, especially among minorities, new U.S. research suggests. Adult smokers who are younger, have mental health problems and are from racial/ethnic minority groups are more likely to use menthol cigarettesContinue Reading

THURSDAY, Oct. 13, 2022 (HealthDay News) — A new study is sounding the alarm about the addition of antihistamines to street forms of opioids — and how they might make a fatal overdose more likely. The prime drug in question is diphenhydramine, found commonly in over-the-counter allergy meds such asContinue Reading

THURSDAY, Oct. 13, 2022 (HealthDay News) — The COVID-19 antiviral Paxlovid has been a game-changer in the global pandemic, shielding high-risk patients from the coronavirus’ most devastating effects. But Paxlovid can itself pose a risk for people taking widely prescribed heart medications to lower cholesterol, prevent blood clots or manageContinue Reading

MONDAY, Oct. 10, 2022 (HealthDay News) — While politicians and health officials seek solutions to an opioid epidemic that kills tens of thousands every year, doctors who prescribe the pain medications are seeking alternatives for their patients. New research suggests one way to handle pain for minimally invasive knee orContinue Reading

FRIDAY, Oct. 7, 2022 (HealthDay News) — Getting vaccinated and boosted greatly reduces the odds for hospitalization if you get infected with COVID-19, according to a large new study conducted at U.S. Veterans Health Administration facilities. “This is remarkable, good news about the power and effectiveness of receiving COVID-19 boostingContinue Reading

WEDNESDAY, Oct. 5, 2022 (HealthDay News) — Australia is experiencing its worst flu season in five years, and that doesn’t bode well for the United States, federal health officials warned Tuesday. America’s flu season often mirrors what unfolds in Australia, where winter spans April through October. Making matters worse, onlyContinue Reading

WEDNESDAY, Oct. 5, 2022 (HealthDay News) — A new study has found no evidence that COVID-19 shots increase the incidence of Guillain-Barré syndrome, according to researchers. “This is important because we can say that there is no significant increased risk of Guillain-Barré syndrome in the population,” said study first authorContinue Reading

TUESDAY, Oct. 4, 2022 (HealthDay News) — While certain minority groups are more likely to be diagnosed with dementia than their white counterparts, they may also be less likely to be eligible for new disease-slowing treatments, a new study finds. Cognitive, or mental, impairment in Black, Hispanic and Asian patientsContinue Reading